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Key questions
What is already known?
 ► Conflict has especially devastating consequences 
for the implementation and delivery of health inter-
ventions for women, children and adolescents, in-
cluding infectious disease interventions.
 ► Often, there are resurgences of infectious diseases 
such as HIV transmission, polio, measles and other 
vaccine- preventable diseases due to severed access 
to standard prevention and treatment services.
What are the new findings?
 ► In many conflict settings, coverage rates of infec-
tious disease interventions are challenging to ascer-
tain and are often unknown.
 ► Health workers, and the infrastructure and sys-
tems that support them, are debilitated by conflict. 
Prioritising local communities’ needs and working 
collaboratively with multiple sectors to develop ho-
listic and sustainable solutions that address security 
concerns is crucial in restoring operational functions 
to deliver essential infectious disease services.
What do the new findings imply?
 ► High- quality research is required to identify 
evidence- based infectious disease interventions to 
further support its provision and uptake in conflict- 
affected settings.
 ► There must be a greater focus on enhancing the 
availability of health data, as it relates to infectious 
diseases, of women and children in conflict settings. 
Accessible and timely data will encourage account-
ability and aid in the coordination of multiple actors 
across country, regional and global levels.
AbsTrACT
background Conflict has played a role in the large- 
scale deterioration of health systems in low- income and 
middle- income countries (LMICs) and increased risk of 
infections and outbreaks. This systematic review aimed 
to synthesise the literature on mechanisms of delivery 
for a range of infectious disease- related interventions 
provided to conflict- affected women, children and 
adolescents.
Methods We searched Medline, Embase, CINAHL and 
PsychINFO databases for literature published in English 
from January 1990 to March 2018. Eligible publications 
reported on conflict- affected neonates, children, 
adolescents or women in LMICs who received an infectious 
disease intervention. We extracted and synthesised 
information on delivery characteristics, including delivery 
site and personnel involved, as well as barriers and 
facilitators, and we tabulated reported intervention 
coverage and effectiveness data.
results A majority of the 194 eligible publications 
reported on intervention delivery in sub- Saharan Africa. 
Vaccines for measles and polio were the most commonly 
reported interventions, followed by malaria treatment. 
Over two- thirds of reported interventions were delivered 
in camp settings for displaced families. The use of clinics 
as a delivery site was reported across all intervention 
types, but outreach and community- based delivery 
were also reported for many interventions. Key barriers 
to service delivery included restricted access to target 
populations; conversely, adopting social mobilisation 
strategies and collaborating with community figures 
were reported as facilitating intervention delivery. Few 
publications reported on intervention coverage, mostly 
reporting variable coverage for vaccines, and fewer 
reported on intervention effectiveness, mostly for malaria 
treatment regimens.
Conclusions Despite an increased focus on health 
outcomes in humanitarian crises, our review highlights 
important gaps in the literature on intervention delivery 
among specific subpopulations and geographies. This 
indicates a need for more rigorous research and reporting 
on effective strategies for delivering infectious disease 
interventions in different conflict contexts.
PrOsPErO registration number CRD42019125221.
InTrOduCTIOn
Significant gaps in access to infectious disease 
interventions within health systems exist glob-
ally and are further impeded by war, civil 
unrest and political violence.1 The popula-
tions most vulnerable to infectious disease 
transmission are those who are relegated to 
live in crowded conditions with inadequate 
shelter, poor sanitation, insufficient water 
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quality and quantity, limited food security and a lack of 
access to essential healthcare services.2 These risk factors 
are major contextual determinants of child malnutrition, 
outbreaks of communicable diseases and low immunisa-
tion coverage in many low- income and middle- income 
countries (LMICs).3 Damage to sanitation facilities or a 
scarcity of clean water means that water- borne and vector- 
borne diseases are transmitted rapidly. Moreover, conflict- 
affected countries are potential zones of new emergence 
such as the case of Ebola imported into the Democratic 
Republic of Congo (DRC), and conflict often triggers the 
resurgence of previously controlled vaccine- preventable 
diseases (VPD) due to severed access to standard preven-
tion and treatment services.4 5 For instance, despite fairly 
high preconflict VPD vaccination coverage rates in Syria, 
reports of measles outbreaks and acute flaccid paralysis 
related to poliovirus have become increasingly common.6 
UNICEF figures show that in Syria, routine administra-
tion of first- dose measles- containing- vaccine decreased 
from 82% coverage in 2010 to 54% in 2014.7 Beyond 
hindering the provision of routine immunisations and 
treatment of acute conditions, the breakdown of a health 
system and restricted access to medical supplies can also 
disrupt the continuum of care for long- term treatment 
courses such as for HIV or tuberculosis (TB).1
Similar to the case in LMICs where armed conflict is 
absent, acute respiratory infections (ARI, most notably 
pneumonia), TB, diarrhoea, measles and malaria 
account for the highest morbidity among children in 
crisis- affected populations.8 However, a lack of consensus 
on effective intervention implementation strategies and 
disrupted routine surveillance make it difficult to coor-
dinate sound public health responses in such settings.9 
To address this difficulty and help improve the quality 
of humanitarian response, a group of non- governmental 
organisations (NGOs) and the Red Cross and Red 
Crescent Movement collectively developed a humani-
tarian charter and a set of minimum standards as part 
of the Sphere Project initiated in 1997. Now in its fourth 
edition, the Sphere Handbook outlines minimum standards 
for humanitarian response across a range of sectors, 
including WASH, shelter, health and nutrition. It also 
outlines key actions for controlling infectious diseases in 
emergency settings: (1) swiftly implementing prevention 
measures; (2) establishing surveillance and reporting 
systems; (3) active diagnosis and case management and 
(4) outbreak preparedness and response in a timely and 
efficient manner.10 However, the Sphere Handbook does not 
sufficiently address how best to implement such actions, 
and there is little evidence- based guidance on implemen-
tation available elsewhere.10
Stronger scientific evidence on implementing effec-
tive infectious disease interventions is needed to 
effectively respond to humanitarian crises. Previous 
reviews have systematically characterised the evidence 
on the effectiveness of infectious disease interven-
tions during humanitarian crises.11 12 Though there 
has been increased international focus to produce and 
disseminate systematic and comprehensive guidelines 
for the delivery of infectious disease services in conflict 
settings, significant challenges remain in terms of provi-
sion and utilisation of critical health interventions.13 This 
paper is part of a set of eight systematic reviews using a 
common protocol to examine the delivery of reproduc-
tive, maternal, newborn, child and adolescent health and 
nutrition interventions in conflict settings, motivated by 
the urgent need to better address the vulnerabilities of 
women and children in humanitarian crises generally 
and in conflict settings particularly.14 15 Here we aimed to 
systematically characterise the literature on the delivery 
of infectious disease interventions to women, children 
and adolescents and identify key gaps in that literature; 
and to synthesise reported information on intervention 
delivery characteristics, including how they may vary by 
setting and by population displacement status.
METHOds
search strategy
A systematic search of indexed literature published 
from 1 January 1990 to 31 March 2018 was conducted 
in Medline, Embase, CINAHL and PsychINFO databases 
using OVID and EBSCO interfaces. The ‘Explode’ func-
tion for the Medical Subject Heading Terms was acti-
vated for main sets of terms related to three concepts: 
(a) conflict; (b) women and children and (c) infectious 
diseases. Conflict- related search terms included war, 
crisis, refugees, internally displaced person (IDP) and 
stateless. Population- related terms included newborn, 
children, adolescents, women and pregnant. Infectious- 
disease- related terms included immunisation, cholera, 
measles, HIV, TB and other disease terms. The complete 
search syntax for Medline is presented in online supple-
mentary appendix A. We also screened reference lists of 
key systematic reviews conducted previously in the field 
of humanitarian health.
For grey literature, we searched the websites of 10 major 
humanitarian agencies and organisations that are actively 
involved in responding to or researching conflict situa-
tions for reports on the delivery of health interventions 
in our population of interest. These websites included 
Emergency Nutrition Network, International Committee 
of the Red Cross, International Rescue Committee, 
Médecins Sans Frontières, Save the Children, United 
Nations Population Fund, United Nations High Commis-
sioner for Refugees, United Nations Children’s Fund, 
Women’s Refugee Commission and World Vision. We 
used broad terms for conflict and health interventions 
tailored to the search functionality of each website. Grey 
literature documents published from 1 January 2013 to 
30 November 2018 were reviewed.
Eligibility criteria
Eligible publications were limited to those reporting 
on populations affected by conflict in LMICs, as classi-
fied by the World Bank.16 The intervention must have 
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Figure 1 Preferred Reporting Items for Systematic Reviews and Meta- Analyses flow diagram: publication selection process 
for systematic review on the delivery of infectious disease interventions to women and children in conflict settings.
targeted or included neonates, children, adolescents or 
women of reproductive age. The publication must have 
also described an intervention being delivered during or 
within 5 years of cessation of conflict. A 5- year cut- off was 
applied to help ensure that we were capturing human-
itarian rather than broader development contexts, and 
assuming that it may take recovering LMICs up to 5 years 
to be able to use foreign aid impactfully.17 If ongoing or 
recent cessation of conflict was not referred to explicitly 
in the publication, we consulted online encyclopaedic 
sources as well as the UN Office for the Coordination of 
Humanitarian Affairs website for information on conflict 
duration, to assess whether the reported time period of 
intervention delivery met the 5- year cut- off criterion. To 
identify the most informative resources from the large 
volume of grey literature that we retrieved even using 
a shorter publication window, the same population and 
intervention delivery period criteria used for the indexed 
literature were applied, along with an additional require-
ment of explicit reporting in the grey literature on the 
delivery site and personnel for each intervention.
Non- English publications; case reports of single 
patients; publications reporting on military personnel, 
refugee populations bound for a high- income country, 
surgical techniques, economic or mathematical model-
ling; and editorials and opinion pieces were excluded 
from our review. Other exclusion criteria included 
systematic reviews, guidelines and publications where 
no specific health intervention was described (eg, prev-
alence studies).
data extraction and analysis
All identified indexed records were downloaded into 
EndNote software and duplicates were removed. Unique 
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Table 1 Summary of publication characteristics (n=194)*
Geographic region n
Sub- Saharan Africa 106
East Asia and Pacific 41
South Asia 26
Middle East and North Africa 15
Europe and Central Asia 3
Latin America and the Caribbean 3
Publication type n
Non- research report 44
Mixed methods 5
Observational 104
Non- randomised controlled trial 5
Randomised controlled trial 36




Children<5 years only 27
Adolescents 0












*Refer to online supplementary appendix B for detailed information 
on included publications.
†Publications may be included in more than one category.
‡Only reflects publications that reported on displaced populations 
(refugees, IDPS, or returning refugees).
IDP, internally displaced person.
records were then imported into Covidence software 
for screening. Titles and abstracts were screened for 
relevance in duplicate, and the full- text of each poten-
tially relevant publication was then screened by a single 
reviewer who noted reasons for exclusion at this stage.
Relevant information and data from the eligible 
indexed and grey literature were extracted in duplicate 
into a customised and piloted form using REDCap soft-
ware. Key variables included publication author, publi-
cation year, study design, setting, target population 
characteristics, intervention characteristics and delivery 
characteristics, including any author- reported narrative 
information on delivery barriers or facilitators. We also 
extracted reported quantitative data on intervention 
coverage and effectiveness (eg, sample size, point esti-
mates, SD or errors, 95% CIs, p- values). The double- entry 
data were matched and any discrepancies were resolved 
through discussion, or by a third reviewer if needed.
We generated descriptive statistics to summarise key 
population and intervention characteristics, including 
population displacement status and intervention delivery 
characteristics, and we narratively synthesised factors 
inhibiting or facilitating the implementation of interven-
tions by grouping reported information into common 
themes. We tabulated reported quantitative data on 
coverage and effectiveness; given the wide range of inter-
ventions, geographic settings, populations and delivery 
approaches across the publications, we did not undertake 
meta- analysis.
rEsulTs
A total of 37 436 unique citations were retrieved from 
indexed databases, with 170 ultimately assessed as eligible 
(figure 1). From the screening and assessment of the grey 
literature and of the reference lists of relevant systematic 
reviews, a further 24 eligible publications were identified. 
From the total of 194 eligible publications18–211 included 
in our review (table 1; online supplementary appendix 
B), we captured 392 reported instances of infectious 
disease intervention delivery. Publication frequency 
varied since the beginning of the review study period in 
1990, with peaks in 1996 and again in 2013 (n=26), and 
remaining high since then (figure 2). The frequency of 
reported intervention start years also varied, with a peak 
in 1994 relating to the genocide in Rwanda and a similar 
peak in 2005 relating to civil war in DRC, and later peaks 
in 2011 and 2013 relating to the conflict in Syria.
In regards to the geographic distribution of the 
included publications, more than half reported on 
intervention delivery in sub- Saharan Africa (106/194, 
55%), most frequently in the DRC, South Sudan, Sudan, 
Tanzania and Ethiopia (figure 3). About 20% of included 
publications (41/194) were focused in East Asia, with 
Thailand accounting for the vast majority of these (36/41, 
88%). South Asia (26 publications, 13%) and the Middle 
East and North Africa (15 publications, 8%) were the 
next most frequent regions, with the fewest publications 
focusing in Latin America (three publications, 2%), only 
consisting of El Salvador and Nicaragua, and Europe and 
Central Asia (three publications, 2%), including Mace-
donia and Azerbaijan. Of the included publications, 
53% reported on intervention delivery in refugee popu-
lations and 30% in IDP populations. Publications from 
Uganda, South Sudan, DRC and Sudan predominantly 
focused on delivery to IDPs; publications from Thailand, 
Tanzania and Pakistan mostly focused on delivery to 
refugees from neighbouring countries (figure 4). Nearly 
80% of publications reporting on intervention delivery 
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Figure 2 Publications counts by (a) publication year and (b) intervention start year.
to conflict- affected populations that were not displaced 
were focused in sub- Saharan Africa.
Overall, vaccines were the most commonly reported 
intervention delivered (figure 5). For interventions 
where there were mass immunisation campaigns, polio 
and measles vaccines were the most frequently reported 
vaccines administered to children under five. These 
high priority vaccines were often reported to be deliv-
ered in conjunction with one another. Vitamin A was 
also frequently reported to be given in conjunction with 
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Figure 3 Geographic distribution of included publications.
the measles vaccine. The delivery of cholera and diph-
theria, tetanus and pertussis (DTP) vaccines were also 
frequently reported. After vaccines, malaria treatment 
was the second most commonly reported interven-
tion, followed by screening for infectious diseases and 
behaviour change or education interventions. Screening 
for HIV or other sexually transmitted infections (STIs) 
was often reported to be integrated into antenatal care. 
Of the 49 reported instances of a screening interven-
tion, 27 targeted HIV/STIs (56%), and 10 screened for 
malaria (21%); the remaining were for TB referrals. 
Behaviour change or education interventions accounted 
for 12% of reported interventions delivered. Exam-
ples of these interventions included condom provision, 
hygiene promotion and psychosocial support services. 
About 62% of the 392 reported instances of interven-
tion delivery occurred in camp settings, and about 30% 
in non- camp environments, with the remaining 8% 
occurring among conflict- affected populations who were 
not displaced. Among both refugees and IDPs, a large 
majority of reported interventions were delivered within 
camps compared with out of camps, particularly vaccines 
(figure 5). The relative frequency of different interven-
tion types was similar in both settings.
The delivery of interventions was categorised into three 
tiers of the care continuum: ‘outpatient’, consisting of 
delivery in hospitals and clinics; ‘outreach’, where service 
mobility is a component, such as delivery through tempo-
rary health posts or mobile clinics and ‘community- 
based’ care, which includes intervention delivery in 
homes, markets, places of worship, schools or other 
communal spaces (figure 6). Clinics were used as delivery 
sites for all reported intervention types, but outreach and 
community- based delivery were also common levels of 
care for intervention delivery. In terms of home- based 
delivery, malaria prevention interventions (eg, the distri-
bution of insecticide- treated nets and indoor residual 
spraying) were the most frequently reported, while 
vaccines were also often delivered at the home using door- 
to- door strategies. Reported behaviour change/educa-
tion interventions were mostly delivered in community 
settings, using the broadest range of delivery personnel 
types (figure 7). UN/NGO staff and health workers were 
the most frequently reported delivery personnel across 
all displacement settings, including among those who 
were non- displaced. Community health workers (CHWs) 
most often delivered health interventions to homes. 
Skilled birth attendants delivered interventions such as 
prevention of mother- to- child transmission of HIV and 
malaria treatment for pregnant women during antenatal 
care services. In some cases, civic and religious leaders 
were enlisted to encourage the uptake of polio vaccines 
where communities were misinformed or where public 
trust was compromised.185 212
Multiple barriers to implementing and scaling up the 
delivery of infectious disease interventions in conflict 
settings were highlighted in the included literature 
(table 2). Many of the obstacles revolved around limited 
access to target populations due to active combat, as well 
as logistical constraints, especially with the procurement 
and storage of vaccines. Public trepidation and reluc-
tance to use health services delivered by foreign agencies 
also presented as a common barrier accounting for lower 
than expected coverage of some interventions. Other key 
barriers to delivery included a shortage of trained health 
workers, as well as stigma for receiving treatment for 
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Figure 4 Geographic distribution of included publications by population displacement status. IDPs, internally displaced 
persons.
certain illnesses considered taboo, like HIV for example. 
Multiple strategies to counter some of these barriers were 
also documented in the literature. The most notable 
facilitator to implementing interventions was adopting 
social mobilisation strategies by coordinating a multisec-
torial approach. This was accomplished in out- of- camp 
settings by working with the Ministry of Health, engaging 
prominent local leaders, including CHWs in intervention 
delivery and integrating health promotion programmes 
at the community level to ensure accurate and harmon-
ised messaging. Instituting reliable surveillance and 
population data in camp settings was also crucial for the 
roll- out of interventions. Some other common facilita-
tors were capacity building—enriching the knowledge 
and practical skills of local workers, and ensuring that 
intervention delivery had an outreach component so it 
was flexible to move with populations.
Only 15% of included publications (30/194) reported 
data on intervention coverage. Most reported on coverage 
data related to vaccinations, especially polio vaccines for 
children under 5 years and measles vaccine for those 
under 15 years, with some data available on cholera, 
DTP, tetanus, meningitis and TB vaccination coverage 
(online supplementary appendix C). Reported coverage 
rates for polio and measles vaccines often exceeded 
80%. There was no observable difference between polio 
and measles coverage by displacement status or setting. 
Only 7% of publications (13/194) reported data on 
intervention effectiveness, most frequently evaluating 
malaria treatment regimens including different dosages 
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Figure 5 Frequencies of reported interventions delivered (a) overall, (b) in camps and (c) out of camps.
of antimalarial medications, and malaria prevention 




This systematic review identified 194 publications from 
1990 to 2018 that report on delivery modalities of infec-
tious disease interventions for women, children and 
adolescents in conflict- affected zones. While a range 
of delivered interventions was reported in the liter-
ature, interventions for vaccine- preventable diseases 
predominated, particularly for polio and measles virus. 
Malaria treatment in Thailand and infectious disease 
screening, especially for HIV across sub- Saharan Africa, 
were also reported frequently. Though clinic- based 
delivery was evident for all intervention types reported, 
many reported interventions were also delivered using 
outreach approaches, highlighting the advantage of 
mobile health services in many conflict settings. Due 
to the constraints of maintaining and accessing static 
clinics in areas of armed conflict, and because of high 
population movement, health personnel often provided 
interventions through the installation of health posts and 
mobile clinics. Moreover, most reported interventions 
were delivered in camps, likely reflecting the generally 
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Figure 6 Reported intervention delivery sites. DTP, diphtheria, tetanus and pertussis; TB, tuberculosis.
higher access to target populations in these settings, but 
perhaps also reflecting greater documentation of health 
service delivery in camp sites than in other settings. Few 
publications provided estimates for intervention coverage 
and effectiveness, with data for vaccine coverage being 
most commonly reported. Most of the reported inter-
vention coverage and effectiveness data were captured 
from people living in camp settings. Multiple publica-
tions reported that collaboration through participatory 
processes involving prominent community actors, and 
modifying interventions to adapt to the cultural and reli-
gious context led to added coverage and impact. This 
includes inviting key stakeholders and respected commu-
nity leaders to design programmes and assist with the 
dissemination and delivery of interventions.213
Evidence gaps
The results of this review highlight several important gaps 
in the literature, relating to populations, geography and 
targeted health conditions. Very few publications were 
included from Latin America, with none from Colombia, 
despite having the most severe internal displacement 
situation in the world,214 or from other conflict- affected 
countries in the region such as Honduras, Nicaragua 
and El Salvador. Despite the need for adolescent- focused 
sexual and reproductive health programming including 
HIV/STI prevention and treatment in humanitarian 
settings,213 we found no reporting on infectious disease 
interventions targeting adolescents, and therefore no 
evidence on coverage rates in this population group. That 
much of the included literature focuses on the delivery 
of polio and measles vaccination is also not surprising. 
Poliovirus is of great concern in humanitarian crises as 
the move towards eradication is stalled when immunisa-
tion coverage is threatened by conflict; polio eradication 
relies on accessing over 95% of children with vaccines. 
Disturbances to routine immunisation and surveillance 
systems rapidly reduce population immunity, inevitably 
making individuals more susceptible to polio outbreaks. 
Measles is also of concern due to its highly contagious 
nature, especially among young children. Considering 
the mode of transmission, measles outbreaks are exacer-
bated by conflict and inhabiting overcrowded spaces.215 
Nonetheless, the very limited reporting on the delivery of 
interventions for other important infectious disease condi-
tions in the context of conflict is disproportional. Only 
one publication reported on the delivery of interventions 
for ARI including pneumonia, despite ARI morbidity 
often being very high in crowded camp settings.216 There 
was also limited reporting of neglected tropical disease 
(NTD) interventions, despite the elimination of NTDs by 
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Figure 7 Reported intervention delivery personnel. DTP, diphtheria, tetanus and pertussis; TB, tuberculosis.
2020 being a global goal. The major NTD focus in the 
literature was visceral/cutaneous leishmaniasis, likely 
due to the high morbidity and striking symptomology of 
the condition. Many NTDs often spike during warfare, 
with displacement in densely populated spaces, but very 
few publications reported on trachoma, deworming or 
other NTD interventions.217
limitations
Previous reviews of the literature have examined the size 
and quality of the evidence base for infectious disease 
interventions delivered in humanitarian settings,11 12 but 
this review is the first, to our knowledge, to focus on the 
mechanisms of intervention delivery to women and chil-
dren affected by armed conflict. Nonetheless, this system-
atic review has several limitations. Methodologically, 
our decision to restrict the eligible literature to reports 
published only in English means that key information 
may have been missed, considering many conflicts occur 
in regions where English is not widely spoken and many 
humanitarian organisations operate and may document 
their operations in languages other than English. Our 
inclusion of interventions delivered within 5 years of the 
cessation of a conflict means that some interventions 
delivered during peacetime may also have been included 
inadvertently, potentially biassing our findings on how 
and by whom these interventions have been delivered in 
conflict settings and what the key delivery barriers and 
facilitators have been. The vast majority of the publica-
tions included in our review referred explicitly to delivery 
in a conflict context however, and so we would expect 
the influence of peacetime intervention delivery on our 
findings to be minimal. Furthermore, our approach in 
conducting a comprehensive but not exhaustive search 
of the grey literature means that we will have excluded 
other relevant publications, some of which may have 
provided different information on intervention delivery 
than what we have currently captured.
Beyond the limitations of our methodological 
approach, several limitations derive from the nature of 
the literature itself: much humanitarian health action 
goes undocumented and is not evaluated, and so it is 
not possible to estimate how well the infectious disease 
interventions and delivery patterns that have been 
reported and are captured here actually reflect those on 
the ground. Specifically, reporting on the coverage and 
effectiveness of these interventions was very poor. This 
major gap is likely due to multiple factors that make 
the monitoring and evaluation of intervention delivery 
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Table 2 Barriers and facilitators to the delivery of infectious disease interventions in conflict settings
Barriers
General themes Examples
Constrained access Difficulty accessing target populations due to ongoing conflict, insecurity and armed insurgency. This includes bans 
on health services and attacks on health workers by antigovernment groups or armed militia.
A challenging physical environment, for example: rainy seasons, winter weather or long distances.
Community buy- in Lack of community support and political hesitancy to embrace health campaigns from foreign agencies.
Mistrust and misinformation from local community members, particularly around the administration of polio vaccines.
Poor infrastructure Destruction of health infrastructure and a lack of transit centres along borders, causing limited access to facilities for 
care provision.
Displaced persons who established living quarters in crowded areas with scarce sanitation and poor water supply, 
further facilitating an environment for the spread of highly infectious diseases like measles and poliovirus.
Logistics Logistical problems with supply chain, specifically with the storage and shipment of vaccines to various vaccination 
sites.
Resource constraints and rising costs due to the high demand of services, resulting in a shortage of diagnostic tools, 
drugs and equipment.
Human resources Ongoing violence in conflict countries induced an exodus of thousands of doctors and nurses, seriously threatening 
the already strained health system.
Major turnovers of international staff, a shortage of trained health workers and the presence of inexperienced teams 
during the early phases of an intervention contributed to delays in service delivery.
Stigma Challenges noted with introducing HIV care into areas with minimal HIV knowledge; concerns that people diagnosed 
as HIV- positive could face serious negative consequences (eg, abandonment, physical violence, discrimination).
Language barriers with care providers, and a fear of stigmatisation for receiving services for other taboo illnesses.
Mobile populations High patient mobility was challenging for ensuring the continuity of care, particularly for HIV and TB treatment.
Frequent movements of conflict- affected populations also accounted for lower than expected screening members and 
limited vaccination coverage during immunisation efforts.
Facilitators
Social mobilisation Forming strong partnerships with local community leaders (eg, elders, civic and religious figures) who leveraged their 
influence to negotiate access and promote community uptake of health interventions.
Swift coordination with Ministry of Health or other partners in developing comprehensive operational plans to allocate 
resources quickly and efficiently.
Employing strategies to provide knowledge to population; guided by promotion efforts (eg, radio broadcasting, 
precampaign focus- group interviews, etc)
Capacity building Providing skills training to enrich and strengthen the role of CHWs and other national staff who are most familiar with 
the context; particularly useful for behavioural change/education and screening interventions.
Optimising the use of pre- existing resources, facilities and tools with limited resources.
Safeguards and 
resource provision
Ensuring sufficient and working equipment for communication and feedback (eg, telephone/internet connection, 
camera, copier machine and computers). As well as obtaining sufficient resources and long- term commitment from 
aid agencies.
Regular monitoring of the security situation and adapting contingency plans; allowing patients/staff coming from 
distant locations to stay near project sites.
Operational mobility Flexibility to move ‘temporary fixed posts’ (ie, mobile clinics, health posts), frequently in response to caregivers’ 
demand to bring interventions (specifically vaccines) closer to their homes.
Working within closed camps or areas with restricted movement of populations helped to ensure intervention 
coverage and the continuity of care.
Reliable surveillance Instituting sustainable and reliable infectious disease surveillance helped to guide health planning for refugee 
populations.
Detailed mapping of population settlements and their movements, aided in identifying communities with the largest 
target populations.
Negotiating ceasefires Negotiating cease- fire or tranquillity days between warring factions, particularly for national immunisation days, 
allowing health workers to vaccinate children in areas with ongoing conflict.
CHWs, community health workers.
difficult in conflict settings, including insecurity, high 
population mobility and a lack of both human and logis-
tical resources to reliably and systematically collect and 
analyse quality data. Where coverage or effectiveness data 
were reported, very few publications reported gender- 
disaggregated data, precluding any analysis of potential 
gender differences. Further, where documentation of 
delivered interventions does exist (often in non- research 
reports or in cross- sectional studies), detailed informa-
tion is rarely presented on how those interventions were 
delivered (eg, where and by whom, overcoming what 
barriers with what facilitators) or on their coverage or 
effectiveness. Finally, we must recognise that the highly 
contextual nature of humanitarian crises, with great vari-
ation geographically, socially, culturally and politically, 
can produce considerable heterogeneity in intervention 
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delivery patterns and even intervention effectiveness 
across settings.
Potential implications of findings for programming and future 
research
The limited information available on how such inter-
ventions are currently being delivered, and the paucity 
of data on achieved intervention coverage and effective-
ness make recommendations on delivery strategies for 
different conflict contexts difficult to make. Our results 
strongly indicate that more rigorous and timely research 
is needed to identify effective strategies for delivering 
evidence- based infectious disease interventions in 
different conflict contexts. Future data collection should 
also enable gender analyses to be undertaken, to inves-
tigate gendered differences in health needs, access and 
uptake of services.
There is much variation in practice across UN/NGOs 
in programming for infectious disease interventions, 
suggesting a need for further consensus- building to 
develop a comprehensive set of standard operating proce-
dures and implementation protocols for intervention 
delivery that could be accessed, adapted and applied in 
different conflict contexts. In the meantime, it is evident 
that infectious disease intervention planning must 
include components to addresses the security concerns 
of health service beneficiaries as well as providers, with a 
focus on restoring pre- existing facilities and operational 
functions that deliver essential services. At a broader 
level, preventing attacks on healthcare facilities and 
staff requires sustained effort at international, national 
and community levels. Moreover, garnering support 
and acceptance from local communities and influ-
encers, including local authorities, appears to be critical, 
suggesting that health actors should aim to educate those 
around them while maintaining the perception of their 
impartiality and neutrality;218 219 further work to identify 
effective and efficient ways of doing this may be similarly 
critical. Further training and counselling of less- skilled 
health workers to enable appropriate task- shifting/
sharing is required to better exploit delivery opportuni-
ties along the continuum of care, including community- 
based delivery.
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